Novartis raises full-year guidance on Q1 beat, drug sales

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 45 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 63%

Novartis News

Steady Gains,Market Open,Pre-Market Trading Session

Shares of Novartis (NVS) are soaring in Tuesday's pre-market trading session — holding onto steady gains into the market open — after the Swiss...

) are soaring in Tuesday's pre-market trading session — holding onto steady gains into the market open — after the Swiss pharmaceutical giant reported better-than-expected first-quarter earnings and raised its full-year guidance. The robust financial performance was driven primarily by strong sales of the company's innovative heart failure and psoriasis treatment drugs.

The price of gold continues to hit the headlines, but this material is also making waves and should continue to climb for investors. The post Forget Gold: This Other Metal Is Sure to Soar Higher! appeared first on The Motley Fool Canada.Rivian stock hit the market at $78 per share on Nov. 9, 2021, in the largest initial public offering of the year and the seventh-largest U.S. IPO of all time, according to Statista. Find Out: 10...

Canadian AI stocks like Open Text Corp are changing the game. The post 3 Artificial Intelligence Stocks to Buy With $500 and Hold Forever appeared first on The Motley Fool Canada.Tesla has been the most valuable car company on earth for about 1,400 days. Its reign could come to an end.In this piece, we will take a look at Cathie Wood’s latest investment portfolio and her top ten stock picks. If you want to skip our coverage of Ms.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in ERROR

Coin Coin Latest News, Coin Coin Headlines